NYSE:DGXHealthcare
The Bull Case For Quest Diagnostics (DGX) Could Change Following Oncology Test Integration Into OncoEMR - Learn Why
Quest Diagnostics Incorporated recently integrated its Haystack MRD ctDNA test and Comprehensive Genomic Profiling services for solid tumors into Flatiron Health’s OncoEMR via a pilot with American Oncology Network and other community providers, giving 4,700 clinicians at 1,600 U.S. cancer care locations easier access to these tests within their existing electronic health record workflows.
This move makes Quest the largest clinical reference lab to plug advanced oncology testing directly...